Binz JG - Search Results

1

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.

Brown KK, Henke BR, Blanchard SG, Cobb JE, Mook R, Kaldor I, Kliewer SA, Lehmann JM, Lenhard JM, Harrington WW, Novak PJ, Faison W, Binz JG, Hashim MA, Oliver WO, Brown HR, Parks DJ, Plunket KD, Tong WQ, Menius JA, Adkison K, Noble SA, Willson TM. Brown KK, et al. Among authors: binz jg. Diabetes. 1999 Jul;48(7):1415-24. doi: 10.2337/diabetes.48.7.1415. Diabetes. 1999. PMID: 10389847

2

The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction.

Lenhard JM, Lancaster ME, Paulik MA, Weiel JE, Binz JG, Sundseth SS, Gaskill BA, Lightfoot RM, Brown HR. Lenhard JM, et al. Among authors: binz jg. Diabetologia. 1999 May;42(5):545-54. doi: 10.1007/s001250051193. Diabetologia. 1999. PMID: 10333046

3

GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats.

Chen L, Yang B, McNulty JA, Clifton LG, Binz JG, Grimes AM, Strum JC, Harrington WW, Chen Z, Balon TW, Stimpson SA, Brown KK. Chen L, et al. Among authors: binz jg. J Pharmacol Exp Ther. 2005 Feb;312(2):718-25. doi: 10.1124/jpet.104.074088. Epub 2004 Oct 8. J Pharmacol Exp Ther. 2005. PMID: 15475592

4

Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.

Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, MacKenzie KI, Mansfield TA, Kliewer SA, Goodwin B, Jones SA. Liu Y, et al. J Clin Invest. 2003 Dec;112(11):1678-87. doi: 10.1172/JCI18945. Epub 2003 Nov 17. J Clin Invest. 2003. PMID: 14623915 Free PMC article.

5

Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.

Collins JL, Fivush AM, Watson MA, Galardi CM, Lewis MC, Moore LB, Parks DJ, Wilson JG, Tippin TK, Binz JG, Plunket KD, Morgan DG, Beaudet EJ, Whitney KD, Kliewer SA, Willson TM. Collins JL, et al. Among authors: binz jg. J Med Chem. 2002 May 9;45(10):1963-6. doi: 10.1021/jm0255116. J Med Chem. 2002. PMID: 11985463

6

Synergistic Effects of a GPR119 Agonist with Metformin on Weight Loss in Diet-Induced Obese Mice.

Al-Barazanji K, McNulty J, Binz J, Generaux C, Benson W, Young A, Chen L. Al-Barazanji K, et al. J Pharmacol Exp Ther. 2015 Jun;353(3):496-504. doi: 10.1124/jpet.115.222828. Epub 2015 Mar 13. J Pharmacol Exp Ther. 2015. PMID: 25770135

7

Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats.

Conway JG, Pink H, Bergquist ML, Han B, Depee S, Tadepalli S, Lin P, Crumrine RC, Binz J, Clark RL, Selph JL, Stimpson SA, Hutchins JT, Chamberlain SD, Brodie TA. Conway JG, et al. Among authors: binz j. J Pharmacol Exp Ther. 2008 Jul;326(1):41-50. doi: 10.1124/jpet.107.129429. Epub 2008 Apr 23. J Pharmacol Exp Ther. 2008. PMID: 18434589

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters